IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1176-1200 out of 1292.

<< < 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 > >>

Public Release: 13-Feb-2014
Nature Communications
Metal implants may cut chemotherapy side effects, study suggests
Cancer patients could one day experience fewer side effects from chemotherapy following a discovery from University of Edinburgh researchers that opens the door for more targeted treatments.

Contact: Jen Middleton
University of Edinburgh

Public Release: 13-Feb-2014
Biomedical Materials
Cancer drugs hitch a ride on 'smart' gold nanoshells
Nanoparticles capable of delivering drugs to specifically targeted cancer cells have been created by a group of researchers from China.

Contact: Michael Bishop
Institute of Physics

Public Release: 13-Feb-2014
PLOS Genetics
Discovery may help to explain mystery of 'missing' genetic risk
A new study could help to answer an important riddle in our understanding of genetics: why research to look for the genetic causes of common diseases has failed to explain more than a fraction of the heritable risk of developing them.

Contact: Hennry French

Public Release: 13-Feb-2014
Proceedings of the National Academy of Sciences
Case Comprehensive Cancer Center researchers discover pathway of protein that helps cancer cells survive
A team of researchers from Case Western Reserve School of Medicine has discovered how the cancer-related protein Bcl-2 signals cancer cells to live longer. The breakthrough emerged when the scientists discovered that Bcl-2 alters the level of calcium ions in lymphoma and leukemia cells that are resistant to cancer treatments.
National Institutes of Health

Contact: Christine A. Somosi
Case Western Reserve University

Public Release: 13-Feb-2014
Cancer Research
Laboratory detective work points to potential therapy for rare, drug-resistant cancer
University of Pittsburgh Cancer Institute scientists have shown that old drugs might be able to do new tricks. By screening a library of FDA-approved anticancer drugs that previously wouldn't have been considered as a treatment for a rare type of cancer, UPCI scientists were surprised when they found several potential possibilities to try if the cancer becomes resistant to standard drug treatment.
American Cancer Society, Life Raft Group, GIST Cancer Research Fund, Howard Hughes Medical Institute

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Public Release: 13-Feb-2014
PLOS Pathogens
Efficient treatment a step closer in the fight against cancer-causing herpes
Herpes virus proteins are more "spaghetti-like" than previously thought, which provides a vital clue in the search for an efficient treatment against a type of herpes which causes a form of cancer known as Kaposi's sarcoma.
Biotechnology and Biological Sciences Research Council

Contact: Kath Paddison
University of Manchester

Public Release: 13-Feb-2014
Society for Personality and Social Psychology 15th Annual Meeting
For understanding family structure to trauma: New technology is yielding bigger data
Social media can do more than just entertain us and keep us connected. It also can help scientists better understand human behavior and social dynamics. The volume of data created through new technology and social media such as Facebook and Twitter is lending insight into everything from mapping modern family dynamics to predicting postpartum depression.

Contact: Chad Rummel
Society for Personality and Social Psychology

Public Release: 13-Feb-2014
Science Signaling
A new target for cancer and diabetes: A novel role for the adaptor protein p66shc in regulating glucose metabolism
A protein that has been known until recently as part of a complex communications network within the cell also plays a direct role in regulating sugar metabolism, according to a new study published online in the journal Science Signaling.

Contact: Mohamed Soliman
Lunenfeld-Tanenbaum Research Institute

Public Release: 13-Feb-2014
PLOS Genetics
Discovery may help to explain mystery of 'missing' genetic risk
A new study could help to answer an important riddle in our understanding of genetics: why research to look for the genetic causes of common diseases has failed to explain more than a fraction of the heritable risk of developing them.

Contact: Henry French
Institute of Cancer Research

Public Release: 13-Feb-2014
Journal of the American Academy of Dermatology
Study: Beauty not disease motivates teens to wear sunscreen
"If our endgame is to modify their behavior, we need to tailor our message in the right way and in this case the right way is by highlighting consequences to appearance rather than health," says April Armstrong, lead researcher.

Contact: Garth Sundem
University of Colorado Denver

Public Release: 13-Feb-2014
A promising new approach for treating leukemia discovered
A group of researchers at the Institute for Research in Immunology and Cancer (IRIC) of Université de Montréal discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression.

Contact: William Raillant-Clark
University of Montreal

Public Release: 12-Feb-2014
British Journal of Cancer
Prostate cancer advance could improve treatment options
Researchers at the University of East Anglia have made an important advance in understanding genetic changes associated with terminal prostate cancer. The research highlights why relapses could happen in some men following hormone therapy. And it could help identify those patients that will develop fatal prostate cancer much earlier for life-extending therapy.
Association for International Cancer Research

Contact: Lisa Horton
University of East Anglia

Public Release: 12-Feb-2014
Royal Society B
Bees fight to a stalemate in the battle of the sexes according to new research
A new study sheds light on genomic conflict in bumblebees.

Contact: Dr. Eamonn Mallon
University of Leicester

Public Release: 12-Feb-2014
Cell Cycle
New study explains how dense breast tissue drives the early stages of cancer
Scientists from The University of Manchester working with IBM Research have identified a key biological mechanism that for the first time explains why women with dense breast tissue are at greater risk of developing breast cancer.

Contact: Andrew Thompson
Landes Bioscience

Public Release: 12-Feb-2014
Cancer researchers discover pre-leukemic stem cell at root of AML, relapse
Cancer researchers led by stem cell scientist Dr. John Dick have discovered a pre-leukemic stem cell that may be the first step in initiating disease and also the culprit that evades therapy and triggers relapse in patients with acute myeloid leukemia.

Contact: Jane Finlayson
University Health Network

Public Release: 12-Feb-2014
'Viewpoint' addresses IOM report on genome-based therapeutics and companion diagnostics
The promise of personalized medicine is the ability to tailor therapy to the patient's genome and their cancer's genome using a series of tests, but the system guiding the development of those tests is complex, and plagued with challenges.

Contact: Jennifer Nachbur
University of Vermont

Public Release: 12-Feb-2014
Study highlights long-term effects of childhood obesity on late-life health
"It may be that childhood obesity changes the way the whole metabolism is working -- and changes it during a critical developmental time frame," says Kristen Nadeau, M.D., investigator at the CU Cancer Center.

Contact: Garth Sundem
University of Colorado Denver

Public Release: 12-Feb-2014
Infection Control and Hospital Epidemiology
Rare bacteria outbreak in cancer clinic tied to lapse in infection control procedure
Improper handling of intravenous saline at a West Virginia outpatient oncology clinic was linked with the first reported outbreak of Tsukamurella spp., gram-positive bacteria that rarely cause disease in humans, in a new report from the Centers for Disease Control and Prevention. The report was published in the March issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

Contact: Tamara Moore
Society for Healthcare Epidemiology of America

Public Release: 12-Feb-2014
Journal of Antimicrobial Chemotherapy
Popular disinfectants do not kill HPV
Commonly used disinfectants do not kill human papillomavirus (HPV) that makes possible non-sexual transmission of the virus, thus creating a need for hospital policy changes, according to researchers from Penn State College of Medicine and Brigham Young University.
NIH/National Institute of Allergy and Infectious Diseases, Brigham Young University

Contact: Matthew Solovey
Penn State

Public Release: 11-Feb-2014
Cancer Cell
New UK study shows potential for targeting aggressive breast cancers
A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition program in human cells, may provide an effective approach for treating triple-negative breast cancer.

Contact: Allison Perry
University of Kentucky

Public Release: 11-Feb-2014
New target isolated for leukemia drug development
The protein WTAP and its relationship to Heat shock protein 90 are two discoveries at The University of Texas Health Science Center at San Antonio that open the door to developing more effective therapies in Acute Myeloid Leukemia.
Castella Endowment for Aging Research; NIH/National Cancer Institute, National Institutes of Health, Hyundai Hope on Wheels

Contact: Elizabeth Allen
University of Texas Health Science Center at San Antonio

Public Release: 11-Feb-2014
Proceedings of the National Academy of Sciences
UNC study reveals potential route to bladder cancer diagnostics, treatments
UNC School of Medicine researchers conducted a genetic analysis of invasive bladder cancer tumors to discover that the disease shares genetic similarities with two forms of breast cancer.
National Institutes of Health

Contact: William Davis
University of North Carolina Health Care

Public Release: 11-Feb-2014
British Medical Journal
Double mastectomy halves death risk for women with BRCA-related breast cancer
Women with BRCA-related breast cancer who have a double mastectomy are nearly 50 percent less likely to die of breast cancer within 20 years of diagnosis compared to women who have a single mastectomy, according to a new study led by Women's College Hospital's Kelly Metcalfe.

Contact: Julie Saccone
416-323-6400 x4054
Women's College Hospital

Public Release: 11-Feb-2014
Radiotherapy & Oncology
Skin reactions during radiation therapy preventable
Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of treatment, a clinical trial shows.

Contact: Patries Herst
University of Otago

Public Release: 11-Feb-2014
Researchers find source of new lineage of immune cells
The elusive progenitor cells that give rise to innate lymphoid cells -- a recently discovered group of infection-fighting white blood cells -- have been identified in fetal liver and adult bone marrow of mice.
National Institutes of Health, Howard Hughes Medical Institute

Contact: John Easton
University of Chicago Medical Center

Showing releases 1176-1200 out of 1292.

<< < 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 > >>

  Search News Releases